The Ebola outbreak in the Democratic Republic of the Congo (DRC) surpassed 10,000 confirmed cases on Tuesday, with 4,887 deaths recorded since the epidemic was declared in May.

The Ebola outbreak in the Democratic Republic of the Congo crossed a critical line on October 27, when confirmed infections passed the 10,000 mark. The National Institute of Public Health (INSP), announced the milestone with figures current through October 25.

The official tally stands at 10,060 cases and 4,887 deaths since the outbreak was declared on May 15. In just over five months, the virus has spread well beyond its initial clusters.

RELATED: Ugandans Who Travel DRC Will Spent 21 Quarantine Days at Come Back Due Ebola

Nearly half of those infected have not survived. The case fatality rate reached 48.6%, a level that makes this one of the deadliest health emergencies on record. It also confirms a trend the institute had flagged weeks earlier, when the outbreak first crossed the 9,000 infection mark.

Second Deadliest Ever

Only the West African epidemic of 2014 to 2016 was worse. That crisis left roughly 11,000 dead and 28,000 cases across Guinea, Liberia and Sierra Leone. The current Congolese outbreak now ranks second in global history and has already outpaced the Ebola epidemic that struck the country’s eastern region between 2018 and 2020.

Transmission now spans 66 health zones in eight of the DRC’s 26 provinces, less than a third of the national territory. Ituri and North Kivu carry the heaviest burden. Tshopo, Bas-Uélé, Haut-Uélé, South Kivu, South Ubangi and North Ubangi follow behind. Bafwasende, Beni, Mandima and Bunia face the most critical conditions on the ground, the health agency warned.

“The situation underscores the need to strengthen early detection, contact tracing, dignified and safe burials, and the safety of response teams, especially in Bafwasende, a town in Tshopo province,” National Institute of Public Health’s authorities said.

Recovery figures offer a narrow thread of hope. A total of 2,684 patients have overcome the illness, and contact tracing coverage holds at 81.6%. Even so, the institute described early detection, safe burials and protection for field teams as urgent in the hardest-hit zones.

No Proven Treatment

The outbreak is driven by the Bundibugyo strain, a lineage with no specific treatments. That gap has pushed scientists toward new solutions. The World Health Organization is advancing two experimental vaccines, and their phase 1 human trials have already produced safe profiles.

The country is also running an immunization campaign with Ervebo, a product developed for the Zaire variant that showed favorable signs in animal tests. But the experimental candidates have only reached the earliest stage of evaluation in people, while Ervebo rests on limited preclinical evidence. Neither option yet offers a conclusive tool to stop transmission.

The cumulative data through October 25 shows the epidemic is far from contained. Health workers confront a virus without a specific therapy across a vast territory where contact tracing is uneven. The National Institute of Public Health has already set the immediate priorities, halting the spread and protecting the teams deployed on the ground.

IN THIS ARTICLE